Exercise for Metabolic Syndrome and Fatty Liver in Adolescent Girls with Celiac Disease
Official title: Metaboic Syndrome and Fatty Liver in Celiac Disease Females: Reponse to Exercise in Adolescents
Run by Cairo University · NCT07832994 · Data updated 2026-11-12
This study tests whether a 3-month walking program helps improve metabolic syndrome and fatty liver in adolescent females with celiac disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years to 17 Years |
| Sex | Women only |
| Enrollment | 40 (estimated) |
| Sponsor | Cairo University Academic / other |
| Locations | 1 site (Giza, Dokki) |
| Status | Recruiting |
| Started | August 15, 2026 |
| Main results expected | December 15, 2026 |
| Study ends | December 15, 2026 |
| Registry record updated | September 22, 2026 |
| Trial ID | NCT07832994 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adolescent females with diagnosed celiac disease who also have metabolic syndrome and nonalcoholic fatty liver disease.
✕Probably not a fit
Individuals without metabolic syndrome or fatty liver, or those unable to participate in regular walking, may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study enrolls 40 adolescent girls with celiac disease who also have metabolic syndrome and nonalcoholic fatty liver. Participants are randomized to an exercise group or a wait-list control group; the exercise group performs 40 minutes of treadmill walking three times weekly for three months. The aim is to see if structured aerobic activity can help reduce cardiovascular risk factors associated with the conditions. Outcomes focus on metabolic and liver-related parameters, using standard clinical measures. The study is conducted at Cairo University in Egypt with potential implications for similar patient populations.
Why it matters
Potential benefit: If successful, participants may experience improvements in metabolic health and liver fat, which could reduce long-term cardiovascular risk.
How similar studies have gone: Prior studies in pediatric/adolescent populations suggest aerobic exercise can improve metabolic and liver health, though results vary by population and adherence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * celiac disease * metabolic syndrome * nonalcholic fatty liver Exclusion Criteria: * cardiac disease * renal failure * respiratory disease
Where it's running
-
Cairo University
Giza, Dokki, Egypt Recruiting
Study contacts
- Principal investigator: Ali MA Ismail, PHD — Cairo University
- Study coordinator: Ali MA Ismail, PhD
- Email: ali.mohamed@pt.cu.edu.eg
- Phone: +201005154209
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Fulvic acid supplements for metabolic syndrome
This study tests whether 50 mg or 100 mg of fulvic acid daily for 12 weeks can help people with metabolic syndrome or prediabetes.
-
Asprosin and miRNA Profiles in Young Women with Metabolic Syndrome
This study tests whether certain blood biomarkers, including asprosin and six microRNAs, differ between young women with metabolic syndrome and healthy peers.
-
Mediterranean diet and processed food in adults with celiac disease on a gluten-free diet
This observational study looks at whether following a Mediterranean-style diet or eating more highly processed foods affects GI symptoms and quality of life in adults with celiac disease who have been on a strict gluten-free diet.
-
Using Multimodal Ultrasound to Check Muscle Mass in Metabolic Disease Patients
This study tests whether a multimodal ultrasound approach can accurately measure muscle mass in people with metabolic syndrome, obesity, sarcopenia, or type 2 diabetes.
-
Low-Calorie Diet in adolescents with Familial Mediterranean Fever and metabolic syndrome
A group of adolescents with both FMF and metabolic syndrome will try a low-calorie diet for 3 months to see if it helps manage metabolic symptoms.
-
Longevity Metrics AI/ML Development Study
Researchers are testing AI models that score health screening tests and predict outcomes like life expectancy for adults, using ongoing follow-up data.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.